A Phase I study to evaluate single and multiple (seven) oral doses of SRT2104on the endotoxin induced inflammatory response in healthy male subjects.

Academic Medical Center (AMC), Center of Experimental Molecular Medicine0 个研究点目标入组 24 人开始时间: 待定最近更新: 2024年2月28日

适应症

试验速览

•A subject will be eligible for inclusion in this study only if all of the following criteria apply:
•1. Healthy, as determined by a responsible and experienced physician, based on a
•medical evaluation including medical history, physical examination and laboratory tests
•carried out within 28 days prior to day 1. A subject with a clinical abnormality or
•laboratory parameters outside the reference range for the population being studied may
•be included only if the Investigator and the Medical Monitor agree that the finding is
•unlikely to introduce additional risk factors and will not interfere with the study
•procedures;

•1. Known diseases;
•2. A history of smoking within the last six months, or regular consumption of greater than three units of alcohol per day;

发起方

Academic Medical Center (AMC), Center of Experimental Molecular Medicine